Abstracts

923 – Completeness of COVID-19 Outcomes Among People With HIV Receiving Care in New York City in 2020

Background Many early COVID-19 outcome studies were based exclusively on electronic health record (EHR) data from single health systems. However, many people in 2020 who would have ordinarily received care in the same system experienced outcomes at other hospitals or at home – 2 common scenarios when COVID-19 temporarily transformed usual practice. We assessed completeness…

856 – Human Antibody Repertoire and Allograft Rejection Among Kidney Transplant Recipients With HIV

Background Kidney transplantation (KT) between donors and recipients with HIV is promising. However, allograft rejection risk among recipients with HIV (R+) is higher than recipients without HIV (R-). This study evaluated predictive antibody markers of KT allograft rejection among R+.  Methods The HOPE in Action Multicenter Kidney Trial performed KT in R+ between 2018-2021 from…

938 – Exploring the Molecular Pathways of Long COVID With Post-Exertional Fatigue: A Multiomic Approach

Background Post-exertional malaise (PEM) is a disabling condition characterized by worsened symptoms after mental or physical exertion, commonly seen in Long-COVID (LC). While its underlying pathophysiology is unclear, potential mechanisms include oxidative stress, and metabolic derangements. We conducted a multiomic analysis to identify changes in energy metabolism, immune function and cellular stress responses in patients with…

931 – Immune and Virologic Trajectories 1.5 Years Before and After COVID-19 in an Early-Treated HIV Cohort

Background SARS-CoV-2 infection can be associated with immunologic dysfunction and might serve as a ‘second hit’ to immune function in people with HIV (PWH) despite suppression with antiretroviral therapy (ART). We leveraged the RV254 Thai cohort to examine the trajectory of immunologic and virologic parameters 1.5 years pre- and post-COVID-19 in PWH on stable ART initiated…

924 – COVID-19 Symptoms, Vaccination, and Long COVID Between Cancer Survivors and the US General Population

Background COVID-19 can have lasting symptoms that may vary in different populations. Cancer survivors face many health challenges and may be more vulnerable to COVID-19. This study examined differences in COVID-19 symptoms, vaccination status, and long COVID between cancer survivors and the general population in the US. Methods We conducted a secondary data analysis of…

932 – Longitudinal Changes in Arterial Stiffness and Inflammation From Pre- to Post-COVID-19 Infection

Background We have previously shown in cross-sectional studies that COVID-19 infection was associated with arterial stiffness and increased oxidized LDL (oxLDL).  In this study, we assess changes in these cardiovascular parameters after COVID infection in a group of individuals who have documented pre-COVID assessments.  Having pre-COVID assessments has been a limitation of current studies. Methods…

936 – Preserved Adrenal Function in People With Long COVID

Background Low serum cortisol has been associated with long COVID (LC) in some but not all studies. However, these studies examined untimed cortisol levels, which may not adequately assess adrenal function. Here we assessed untimed, timed, and stimulated cortisol levels and tested their association with LC. Methods Untimed total cortisol levels were quantified in 711…

716 – Tracking Key Remdesivir Resistance Mutations in SARS-CoV-2 Using GISAID Data (2020-2024)

Background The emergence of remdesivir (RDV) resistance mutations poses a potential challenge in treating SARS-CoV-2 infections, especially as the virus continues to evolve globally. GISAID data provides an extensive resource for tracking such mutations. This study aims to investigate the temporal trends and incidence rates of RDV resistance-associated mutations, specifically those conferring a >2.5-fold reduction…

928 – In Vitro Modeling of the Effects of Impaired HDL on Atherogenesis in Long COVID Syndrome

Background The mechanisms that drive SARS-CoV-2-related cardiovascular complications of Long COVID (PASC) such as atherosclerotic cardiovascular disease (CVD) remain unclear. Prior studies have shown alterations of HDL function in infections and SARS-CoV-2 infection, persistent oxidative stress, lipid abnormalities and macrophage dysfunction post COVID-19 that may contribute to HDL dysfunction and CVD. However, the effect of…